BEIJING - The rapid unwinding of China’s Covid restrictions last month triggered a wave of stockpiling of antiviral drugs, including Paxlovid, but access to the treatment has been limited due to low domestic supply.
That opened the door to a thriving black market for Indian generic versions and copies that turned out to be fake.
Already a subscriber? Log in
Read the full story and more at $9.90/month
Get exclusive reports and insights with more than 500 subscriber-only articles every month
ST One Digital
$9.90/month
No contract
ST app access on 1 mobile device
Unlock these benefits
All subscriber-only content on ST app and straitstimes.com
Easy access any time via ST app on 1 mobile device
E-paper with 2-week archive so you won't miss out on content that matters to you
